Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Will Mylan Benefit from Healthcare Reforms?
- Vahan Janjigian Forbes submits: Mylan MYL is a leading provider of generic pharmaceuticals. The company more than doubled its revenue base when it acquired Germany-based Merck MRK KGaA’s generic pharmaceutical business in 2007. This acquisition significantly expanded MYL’s presence in Europe where it generated 35% of generic sales through...
- External links 2008-12-08
- Baxter International: Near-Term Prospects Are Actually Promising
- Vahan Janjigian Forbes submits: Baxter International BAX makes critical and life-sustaining products for treating chronic and acute medical conditions. The company sells these products in more than 100 countries. In fact, 60% of 2008 nine-month sales came from outside the U.S. BAX operates three business segments, each serving a...
- External links 2009-01-11
- C.R. Bard: Going for Growth
- Vahan Janjigian Forbes submits: C.R. Bard BCR makes consumable medical products used for surgical, diagnostic, and patient care purposes. It specializes in the vascular, urology, and oncology markets. These products are typically discarded after a single use. BCR markets its medical products in more than 100 countries. It generated...
- External links 2009-01-12
- Demographic Trends in Amedisys's Favor
- Vahan Janjigian Forbes submits: Amedisys AMED provides home health services to Americans with chronic, multiple, and terminal medical conditions. The company significantly augmented its operations a year ago when it purchased TLC Health Care Services, a privately held provider of home nursing and hospice services. AMED now operates...
- External links 2009-02-09
- Bullish on Millipore's Prospects Despite Risks
- Vahan Janjigian Forbes submits: Millipore MIL provides products and services to the life sciences and pharmaceutical industries. Europe, its largest geographic market, produced 43% of 2008 revenues. The Americas and Asia generated 39% and 18%, respectively. Customers include biotechnology, pharmaceutical and life science companies; contract drug makers; hospital laboratories;...
- External links 2009-06-08
- Inverness Medical Innovations: Significant Market Share Gains Ahead?
- Vahan Janjigian Forbes submits: Inverness Medical Innovations IMA develops advanced professional and consumer medical diagnostic products focused on cardiology, women’s health, infectious disease, oncology and drugs of abuse. The company also provides specialized health management services in the areas of wellness, disease management, oncology, and women and children’s health.The...
- External links 2009-08-09
- << Previous
- page 1 of 1
- Next >>
